Other Stories

Full Video

Moderna to have Omicron-specific booster shot by March Updated: 2021-12-02 17:26:19 KST

U.S. pharmaceutical company Moderna says the company will be ready to seek approval for its COVID-19 booster shot by March next year specifically targeting the new Omicron variant.
According to the company Wednesday they have already been working on a vaccine that's effective against up to four different COVID-19 variants.
U.S. drugmaker Pfizer said Friday the company are capable of producing an Omicron-specific vaccine within 100 days.
A new vaccine would require emergency use authorization from the U.S. FDA.
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.